Fulminant Amebic Colitis after Corticosteroid Therapy: A Systematic Review.

<h4>Background</h4>Amebic colitis, caused by intestinal infection with the parasite, Entamoeba histolytica, is a common cause of diarrhea worldwide. Fulminant amebic colitis is the most devastating complication of this infection, associated with both high mortality and morbidity. We cond...

Full description

Saved in:
Bibliographic Details
Main Authors: Debbie-Ann Shirley, Shannon Moonah
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-07-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0004879&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849431454645223424
author Debbie-Ann Shirley
Shannon Moonah
author_facet Debbie-Ann Shirley
Shannon Moonah
author_sort Debbie-Ann Shirley
collection DOAJ
description <h4>Background</h4>Amebic colitis, caused by intestinal infection with the parasite, Entamoeba histolytica, is a common cause of diarrhea worldwide. Fulminant amebic colitis is the most devastating complication of this infection, associated with both high mortality and morbidity. We conducted a review of the English literature to describe cases of fulminant amebic colitis associated with exposure to corticosteroid medications in order to identify the risk factors for poor outcome and determine difficulties in diagnosis and treatment.<h4>Methodology and principal findings</h4>Articles reporting severe and fulminant forms of amebic colitis between 1991 and 2016 were collected. 525 records were screened to identify 24 cases for qualitative analysis associated with corticosteroid use. Cases arose from areas of high endemicity or travel to such areas. Most cases (14 of 24, 58%) were given corticosteroids for initially misdiagnosed colitis, mainly inflammatory bowel, resulting in rapid progression of disease. Nearly half of all cases underwent surgical intervention, and 25% of cases died, despite all patients eventually receiving treatment with metronidazole. The odds of death did not differ significantly by prior misdiagnosis, co-morbidities, bowel perforation or need for surgery.<h4>Conclusions and significance</h4>Infection with E. histolytica should be considered prior to the administration of corticosteroids, in particular for patients residing in endemic areas or those with appropriate travel history, especially prior to the diagnosis of inflammatory bowel disease. The development of preventative and treatment interventions are needed to improve outcomes of fulminant disease.
format Article
id doaj-art-485fa7e9bce34491a46503f897ae7e3d
institution Kabale University
issn 1935-2727
1935-2735
language English
publishDate 2016-07-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj-art-485fa7e9bce34491a46503f897ae7e3d2025-08-20T03:27:37ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352016-07-01107e000487910.1371/journal.pntd.0004879Fulminant Amebic Colitis after Corticosteroid Therapy: A Systematic Review.Debbie-Ann ShirleyShannon Moonah<h4>Background</h4>Amebic colitis, caused by intestinal infection with the parasite, Entamoeba histolytica, is a common cause of diarrhea worldwide. Fulminant amebic colitis is the most devastating complication of this infection, associated with both high mortality and morbidity. We conducted a review of the English literature to describe cases of fulminant amebic colitis associated with exposure to corticosteroid medications in order to identify the risk factors for poor outcome and determine difficulties in diagnosis and treatment.<h4>Methodology and principal findings</h4>Articles reporting severe and fulminant forms of amebic colitis between 1991 and 2016 were collected. 525 records were screened to identify 24 cases for qualitative analysis associated with corticosteroid use. Cases arose from areas of high endemicity or travel to such areas. Most cases (14 of 24, 58%) were given corticosteroids for initially misdiagnosed colitis, mainly inflammatory bowel, resulting in rapid progression of disease. Nearly half of all cases underwent surgical intervention, and 25% of cases died, despite all patients eventually receiving treatment with metronidazole. The odds of death did not differ significantly by prior misdiagnosis, co-morbidities, bowel perforation or need for surgery.<h4>Conclusions and significance</h4>Infection with E. histolytica should be considered prior to the administration of corticosteroids, in particular for patients residing in endemic areas or those with appropriate travel history, especially prior to the diagnosis of inflammatory bowel disease. The development of preventative and treatment interventions are needed to improve outcomes of fulminant disease.https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0004879&type=printable
spellingShingle Debbie-Ann Shirley
Shannon Moonah
Fulminant Amebic Colitis after Corticosteroid Therapy: A Systematic Review.
PLoS Neglected Tropical Diseases
title Fulminant Amebic Colitis after Corticosteroid Therapy: A Systematic Review.
title_full Fulminant Amebic Colitis after Corticosteroid Therapy: A Systematic Review.
title_fullStr Fulminant Amebic Colitis after Corticosteroid Therapy: A Systematic Review.
title_full_unstemmed Fulminant Amebic Colitis after Corticosteroid Therapy: A Systematic Review.
title_short Fulminant Amebic Colitis after Corticosteroid Therapy: A Systematic Review.
title_sort fulminant amebic colitis after corticosteroid therapy a systematic review
url https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0004879&type=printable
work_keys_str_mv AT debbieannshirley fulminantamebiccolitisaftercorticosteroidtherapyasystematicreview
AT shannonmoonah fulminantamebiccolitisaftercorticosteroidtherapyasystematicreview